tiprankstipranks
Lianbio Sponsored Adr (LIANY)
:LIANY
US Market
Holding LIANY?
Track your performance easily

LianBio Sponsored ADR (LIANY) Stock Price & Analysis

61 Followers

LIANY Stock Chart & Stats


Financials

Annual

Ownership Overview

53.66%0.01%46.32%
53.66% Insiders
0.01% Other Institutional Investors
46.32% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

LIANY FAQ

What was Lianbio Sponsored Adr’s price range in the past 12 months?
Lianbio Sponsored Adr lowest stock price was $0.23 and its highest was $4.99 in the past 12 months.
    What is Lianbio Sponsored Adr’s market cap?
    Lianbio Sponsored Adr’s market cap is $25.28M.
      When is Lianbio Sponsored Adr’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Lianbio Sponsored Adr’s earnings last quarter?
      Currently, no data Available
      Is Lianbio Sponsored Adr overvalued?
      According to Wall Street analysts Lianbio Sponsored Adr’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Lianbio Sponsored Adr pay dividends?
        Lianbio Sponsored Adr pays a Notavailable dividend of $4.75 which represents an annual dividend yield of N/A. See more information on Lianbio Sponsored Adr dividends here
          What is Lianbio Sponsored Adr’s EPS estimate?
          Lianbio Sponsored Adr’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Lianbio Sponsored Adr have?
          Lianbio Sponsored Adr has 108,062,640 shares outstanding.
            What happened to Lianbio Sponsored Adr’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Lianbio Sponsored Adr?
            Currently, no hedge funds are holding shares in LIANY
            ---

            Company Description

            Lianbio Sponsored Adr

            LianBio is a science-driven biopharmaceutical company dedicated to developing and commercializing innovative medicines for patients with unmet medical needs, with an initial focus on in-licensing assets for Greater China and other Asian markets. It is advancing a diversified portfolio of clinically validated product candidates with the potential to drive new standards of care across cardiovascular, oncology, ophthalmology, inflammatory disease and respiratory indications.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Marinus
            Adaptimmune Therapeutics
            Bioxcel Therapeutics
            Karyopharm Therapeutics
            Fate Therapeutics
            Assembly Biosciences
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis